Round Hill Asset Management Trims Stock Holdings in Bausch Health Companies Inc. (NYSE:BHC)

Round Hill Asset Management lowered its position in shares of Bausch Health Companies Inc. (NYSE:BHC) by 4.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 79,755 shares of the company’s stock after selling 4,046 shares during the quarter. Round Hill Asset Management’s holdings in Bausch Health Companies were worth $643,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of BHC. Tobam lifted its position in Bausch Health Companies by 10.4% during the 4th quarter. Tobam now owns 15,034 shares of the company’s stock valued at $121,000 after acquiring an additional 1,422 shares during the period. Wells Fargo & Company MN increased its stake in shares of Bausch Health Companies by 7.9% during the fourth quarter. Wells Fargo & Company MN now owns 25,907 shares of the company’s stock valued at $209,000 after purchasing an additional 1,896 shares in the last quarter. American Century Companies Inc. lifted its holdings in shares of Bausch Health Companies by 10.6% during the fourth quarter. American Century Companies Inc. now owns 27,236 shares of the company’s stock valued at $220,000 after purchasing an additional 2,600 shares during the last quarter. Blair William & Co. IL boosted its position in shares of Bausch Health Companies by 3.2% in the 4th quarter. Blair William & Co. IL now owns 84,707 shares of the company’s stock worth $683,000 after purchasing an additional 2,622 shares in the last quarter. Finally, Sanders Morris Harris LLC boosted its position in shares of Bausch Health Companies by 16.0% in the 4th quarter. Sanders Morris Harris LLC now owns 28,975 shares of the company’s stock worth $234,000 after purchasing an additional 4,000 shares in the last quarter. Institutional investors own 78.65% of the company’s stock.

Wall Street Analyst Weigh In

BHC has been the subject of a number of recent research reports. Jefferies Financial Group reiterated a “hold” rating and set a $8.00 price objective (down previously from $12.00) on shares of Bausch Health Companies in a research note on Thursday, February 6th. Royal Bank of Canada reduced their price target on Bausch Health Companies from $11.00 to $10.00 and set a “sector perform” rating for the company in a report on Thursday, January 30th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $7.42.

Bausch Health Companies Trading Down 5.9 %

Shares of BHC opened at $5.34 on Monday. Bausch Health Companies Inc. has a 12 month low of $3.96 and a 12 month high of $10.46. The business’s fifty day simple moving average is $6.91 and its two-hundred day simple moving average is $7.69. The company has a market cap of $1.96 billion, a price-to-earnings ratio of -44.45, a P/E/G ratio of 0.37 and a beta of 0.43.

Bausch Health Companies (NYSE:BHC) last released its quarterly earnings data on Wednesday, February 19th. The company reported $1.21 EPS for the quarter, missing the consensus estimate of $1.65 by ($0.44). The business had revenue of $2.56 billion during the quarter, compared to the consensus estimate of $2.51 billion. Bausch Health Companies had a negative return on equity of 577.82% and a negative net margin of 0.48%. As a group, research analysts forecast that Bausch Health Companies Inc. will post 4.41 EPS for the current year.

Bausch Health Companies Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.